I've always predicted they will need to go back to the well for more.
And while others here were saying last winter (North American summer) that the stock was about to take off (one guy said it would be $1 by the end of 2009), I said in late July this was dead money for a long time - which turned out to be dead on. I made those comments after Clinuvel released their July newsletter.
Just a reminder that Wolgen said in his Rosacea board interview and the company said in their Feb. newsletter (and on their website) that EPP Phase III results would be out by the end of Q1. So much for that. They consistently keep moving the goalline and saying they are on target. The market obviously doesn't like it.
Just another example of why the stock is trading $1 less than what it was 3 years ago.
just my opinions...GLTA
Ann: Appendix 4C - quarterly , page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |